We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

128 hedge funds and large institutions have $1.2B invested in Immunogen Inc in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more call options, than puts

Call options by funds: $10.4M | Put options by funds: $5.82M

Holders
128
Holders Change
+128
Holders Change %
–
% of All Funds
4.18%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
128
Increased
–
Reduced
–
Closed
–
Calls
$10.4M
Puts
$5.82M
Net Calls
+$4.56M
Net Calls Change
+$4.56M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$210M +$205M +12,680,071 New
Primecap Management
2
Primecap Management
California
$207M +$203M +12,507,427 New
SAM
3
Sectoral Asset Management
Quebec, Canada
$106M +$104M +6,418,984 New
ClearBridge Investments
4
ClearBridge Investments
New York
$106M +$104M +6,388,360 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$77.6M +$75.8M +4,675,560 New
Wellington Management Group
6
Wellington Management Group
Massachusetts
$58.5M +$57.2M +3,528,192 New
BB
7
BB Biotech
Switzerland
$54.1M +$52.9M +3,262,094 New
BFA
8
BlackRock Fund Advisors
California
$45.5M +$44.4M +2,741,850 New
State Street
9
State Street
Massachusetts
$43.1M +$42.1M +2,598,245 New
BIT
10
BlackRock Institutional Trust
California
$40.1M +$39.1M +2,414,605 New
AG
11
Artal Group
Luxembourg
$28.2M +$27.6M +1,700,000 New
First Trust Advisors
12
First Trust Advisors
Illinois
$27.1M +$26.5M +1,635,948 New
Northern Trust
13
Northern Trust
Illinois
$20.1M +$19.6M +1,210,754 New
GIM
14
Granahan Investment Management
Massachusetts
$19.2M +$18.7M +1,156,000 New
PA
15
Pinnacle Associates
New York
$15.8M +$15.4M +949,575 New
Norges Bank
16
Norges Bank
Norway
$10.3M +$10.1M +622,078 New
Deutsche Bank
17
Deutsche Bank
Germany
$9.51M +$9.29M +573,137 New
Morgan Stanley
18
Morgan Stanley
New York
$7.44M +$7.27M +448,741 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$7M +$6.84M +422,055 New
TCM
20
Tekla Capital Management
Massachusetts
$6.53M +$6.38M +393,773 New
Wells Fargo
21
Wells Fargo
California
$6.52M +$6.37M +393,007 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$6.12M +$5.97M +368,587 New
TCIM
23
TIAA CREF Investment Management
New York
$6.08M +$5.94M +366,752 New
BIM
24
BlackRock Investment Management
Delaware
$3.99M +$3.9M +240,378 New
TFCP
25
Twin Focus Capital Partners
Massachusetts
$3.32M +$3.24M +200,000 New
1
2 3 4 5

IMGN Hedge Fund Activity: Q2 2013 in Review

128 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2013, worth a combined $1.2B.

Buyers outnumbered sellers: 128 funds opened new IMGN positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.

  • 128 institutional investors held Immunogen Inc (IMGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.2B of Immunogen Inc stock for Q2 2013.
  • 128 funds opened new Immunogen Inc positions in Q2 2013 and 0 closed out, a net change of +128 holders.

Based on aggregated 13F filings for Q2 2013.